DGAP-News: DATAMETREX: 1COPY(TM) COVID-19 QPCR MULTI KIT DETECTS THE OMICRON VARIANT
Retrieved on:
Thursday, December 9, 2021
COVID-19 testing, DGAP, Company, DM, COVID-19, Technology, Hospital, OTC, Phrase, Artificial intelligence, Death, News, Vaccine, Nature, Jungwon-gu, Machine learning, CE, Health and Safety Executive, Certification, Samsung Electronics, Real-time, TSX Venture Exchange, Solution, FSE, RNA polymerase II, Severe acute respiratory syndrome coronavirus 2, Security (finance), Animal, Medical device, Cryptocurrency, Risk management, 1drop Inc., Datametrex, 1DROP INC., DATAMETREX
TORONTO, CANADA - December 9, 2021- Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the 1copy(TM) COVID-19 qPCR Multi Kit ("qPCR kit") which Company has the rights to sell can detect the Omicron (B.1.1.529) variant.
Key Points:
- TORONTO, CANADA - December 9, 2021- Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the 1copy(TM) COVID-19 qPCR Multi Kit ("qPCR kit") which Company has the rights to sell can detect the Omicron (B.1.1.529) variant.
- The Omicron mutations do not affect the performance of the qPCR kit.
- "The company continues to work with our suppliers to provide a reliable and safe product that our consumers can rely on.
- 1drop is located in Jungwon-gu, South Korea, and was incorporated in 2017 following a technology spin-off from Samsung Electronic's C-Lab program.